The Erythropoietin Receptor is a Downstream Effector of Klotho-induced Cytoprotection

Overview

Journal Kidney Int

Publisher Elsevier

Specialty Nephrology

Date 2013 May 3

PMID 23636173

Citations 36

Authors

Ming-Chang Hu

Mingjun Shi

Han J Cho

Jianning Zhang

Alevtina Pavlenco

Shuzhen Liu

Sachdev Sidhu

Lily J-S Huang

Orson W Moe

Affiliations

Soon will be listed here.

Abstract

Although the role of the erythropoietin (EPO) receptor (EpoR) in erythropoiesis has been known for decades, its role in nonhematopoietic tissues is still not well defined. Klotho has been shown and EPo has been suggested to protect against acute ischemia-reperfusion injury in the kidney. Here we found in rat kidney and in a rat renal tubular epithelial cell line (NRK cells) EpoR transcript and antigen, and EpoR activity signified as EPo-induced phosphorylation of Jak2, ErK, Akt, and Stat5 indicating the presence of functional EpoR. Transgenic overexpression of Klotho or addition of exogenous recombinant Klotho increased kidney EpoR protein and transcript. In NRK cells, Klotho increased EpoR protein, enhanced EPo-triggered phosphorylation of Jak2 and Stat5, the nuclear translocation of phospho-Stat5, and protected NRK cells from hydrogen peroxide cytotoxicity. Knockdown of endogenous EpoR rendered NRK cells more vulnerable, and overexpression of EpoR more resistant to peroxide-induced cytotoxicity, indicating that EpoR mitigates oxidative damage. Knockdown of EpoR by siRNA abolished Epo-induced Jak2, and Stat5 phosphorylation, and blunted the protective effect of Klotho against peroxide-induced cytotoxicity. Thus in the kidney, EpoR and its activity are downstream effectors of Klotho enabling it to function as a cytoprotective protein against oxidative injury.

Citing Articles

Preeclampsia as a Study Model for Aging: The Klotho Gene Paradigm.

Cecati M, Fumarola S, Vaiasicca S, Cianfruglia L, Vignini A, Giannubilo S Int J Mol Sci. 2025; 26(3).

PMID: 39940672 PMC: 11817256. DOI: 10.3390/ijms26030902.

HBSP inhibits tubular cell pyroptosis and apoptosis, promotes macrophage M2 polarization, and protects LPS-induced acute kidney injury.

Huang L, Wu Y, Sai W, Wang Y, Feng G, Lu Y J Cell Mol Med. 2024; 28(22):e70202.

PMID: 39584501 PMC: 11586777. DOI: 10.1111/jcmm.70202.

Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease.

Donate-Correa J, Martin-Carro B, Cannata-Andia J, Mora-Fernandez C, Navarro-Gonzalez J Antioxidants (Basel). 2023; 12(2).

PMID: 36829798 PMC: 9952437. DOI: 10.3390/antiox12020239.

Molecular mechanisms and physiological functions of autophagy in kidney diseases.

Yang J, Yuan L, Liu F, Li L, Liu J, Chen Y Front Pharmacol. 2022; 13:974829.

PMID: 36081940 PMC: 9446454. DOI: 10.3389/fphar.2022.974829.

Administration of α-Klotho Does Not Rescue Renal Anemia in Mice.

Park M, Le Henaff C, Sitara D Front Pediatr. 2022; 10:924915.

PMID: 35813388 PMC: 9259788. DOI: 10.3389/fped.2022.924915.

References

Tang Y, Hasan F, Giordano F, Pfau S, Rinder H, Katz S . Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial. Am Heart J. 2009; 158(6):941-7. PMC: 2838229. DOI: 10.1016/j.ahj.2009.06.032. View

Sharples E, Thiemermann C, Yaqoob M . Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin. Nat Clin Pract Nephrol. 2006; 1(2):87-97. DOI: 10.1038/ncpneph0042. View

GOLDWASSER E . Erythropoietin and the differentiation of red blood cells. Fed Proc. 1975; 34(13):2285-92. View

Kase S, Yoshida K, Osaki M, Adachi H, Ito H, Ohno S . Expression of erythropoietin receptor in human Merkel cell carcinoma of the eyelid. Anticancer Res. 2007; 26(6B):4535-7. View

Hu M, Shiizaki K, Kuro-O M, Moe O . Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013; 75:503-33. PMC: 3770142. DOI: 10.1146/annurev-physiol-030212-183727. View

Lee Y, Vortmeyer A, Lubensky I, Vogel T, Ikejiri B, Ferlicot S . Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Clin Cancer Res. 2005; 11(3):1059-64. View

Eccles T, Patel A, Verma A, Nicholson D, Lukes Y, Tuttle R . Erythropoietin and the erythropoietin receptor are expressed by papillary thyroid carcinoma from children and adolescents. Expression of erythropoietin receptor might be a favorable prognostic indicator. Ann Clin Lab Sci. 2003; 33(4):411-22. View

Wenker S, Chamorro M, Vota D, Callero M, Vittori D, Nesse A . Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid-differentiated SH-SY5Y cells. J Cell Biochem. 2010; 110(1):151-61. DOI: 10.1002/jcb.22521. View

Breggia A, Wojchowski D, Himmelfarb J . JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells. Am J Physiol Renal Physiol. 2008; 295(6):F1689-95. PMC: 2753302. DOI: 10.1152/ajprenal.90333.2008. View

10.

Longmore G, Watowich S, Hilton D, Lodish H . The erythropoietin receptor: its role in hematopoiesis and myeloproliferative diseases. J Cell Biol. 1993; 123(6 Pt 1):1305-8. PMC: 2290895. DOI: 10.1083/jcb.123.6.1305. View

11.

Bi B, Guo J, Marlier A, Lin S, Cantley L . Erythropoietin expands a stromal cell population that can mediate renoprotection. Am J Physiol Renal Physiol. 2008; 295(4):F1017-22. PMC: 2576137. DOI: 10.1152/ajprenal.90218.2008. View

12.

Sulahian R, Cleaver O, Huang L . Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia. Blood. 2009; 113(21):5287-97. PMC: 2686193. DOI: 10.1182/blood-2008-09-179572. View

13.

Sinclair A, Rogers N, Busse L, Archibeque I, Brown W, Kassner P . Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells. Br J Cancer. 2008; 98(6):1059-67. PMC: 2275479. DOI: 10.1038/sj.bjc.6604220. View

14.

Echigoya M, Obikane K, Nakashima T, Sasaki S . Glomerular localization of erythropoietin receptor mRNA and protein in neonatal and mature mouse kidney. Nephron Exp Nephrol. 2005; 100(1):e21-9. DOI: 10.1159/000084109. View

15.

Brines M, Cerami A . Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int. 2006; 70(2):246-50. DOI: 10.1038/sj.ki.5001546. View

16.

David R, Lim G, Moritz K, Koukoulas I, Wintour E . Quantitation of the mRNA levels of Epo and EpoR in various tissues in the ovine fetus. Mol Cell Endocrinol. 2002; 188(1-2):207-18. DOI: 10.1016/s0303-7207(01)00718-3. View

17.

Paragh G, Kumar S, Rakosy Z, Choi S, Xu X, Acs G . RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells. Am J Pathol. 2009; 174(4):1504-14. PMC: 2671380. DOI: 10.2353/ajpath.2009.080592. View

18.

Shimada T, Takeshita Y, Murohara T, Sasaki K, Egami K, Shintani S . Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation. 2004; 110(9):1148-55. DOI: 10.1161/01.CIR.0000139854.74847.99. View

19.

Imamura R, Moriyama T, Isaka Y, Namba Y, Ichimaru N, Takahara S . Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha. Transplantation. 2007; 83(10):1371-9. DOI: 10.1097/01.tp.0000264200.38926.70. View

20.

Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P . Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A. 2003; 100(8):4802-6. PMC: 153636. DOI: 10.1073/pnas.0630444100. View